|
ZNF235 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.051840E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.759500E-04 |
| Normal-vs-Stage2 |
3.286200E-01 |
| Normal-vs-Stage3 |
2.753800E-01 |
| Normal-vs-Stage4 |
1.072810E-01 |
| Stage1-vs-Stage2 |
2.890000E-01 |
| Stage1-vs-Stage3 |
1.51859999999449E-05 |
| Stage1-vs-Stage4 |
4.9948000000466E-06 |
| Stage2-vs-Stage3 |
1.119190E-01 |
| Stage2-vs-Stage4 |
5.372300E-02 |
| Stage3-vs-Stage4 |
5.112600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.923200E-01 |
| Normal-vs-AfricanAmerican |
3.630200E-02 |
| Normal-vs-Asian |
6.689900E-02 |
| Caucasian-vs-AfricanAmerican |
9.220000E-02 |
| Caucasian-vs-Asian |
2.263700E-02 |
| AfricanAmerican-vs-Asian |
2.561800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.161000E-01 |
| Normal-vs-Female |
3.234500E-02 |
| Male-vs-Female |
1.892580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.134200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.093790E-02 |
| Normal-vs-Age(61-80Yrs) |
6.065000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.996000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.065200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.017000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.803400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.980500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.907840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.126600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.058410E-03 |
| Normal-vs-Grade 2 |
1.795180E-04 |
| Normal-vs-Grade 3 |
7.293800E-01 |
| Normal-vs-Grade 4 |
4.560600E-03 |
| Grade 1-vs-Grade 2 |
6.591800E-02 |
| Grade 1-vs-Grade 3 |
1.012120E-04 |
| Grade 1-vs-Grade 4 |
1.42360000010555E-07 |
| Grade 2-vs-Grade 3 |
2.19759999999791E-05 |
| Grade 2-vs-Grade 4 |
3.16979997805333E-09 |
| Grade 3-vs-Grade 4 |
1.315620E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.81629999999845E-05 |
| Normal-vs-ccB subtype |
3.586000E-01 |
| ccA subtype-vs-ccB subtype |
1.67730000000255E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.865200E-01 |
| Normal-vs-N1 |
1.421790E-01 |
| N0-vs-N1 |
9.468400E-02 |
|
|
